On Nov. 9, a Multnomah County jury returned a $7.848 million verdict in a wrongful-death and loss-of-consortium case over a lung mass that plaintiffs said should have been reported on Wendi K. Lui’s April 2019 breast MRI. The jury found radiologist Kari A. Thomas negligent, found her negligence caused Lui’s death, and found she was acting as an actual or apparent agent of Legacy Health and related Legacy entities. The matter proceeded to an 11-day trial, culminating in a Nov. 9 decision in favor of the estate of Wendi K. Lui and her husband, Gene Lui, DO. The case centers on whether a radiologist interpreting a breast MRI must evaluate and report abnormalities in intrathoracic structures that appear on the study, even when the exam is ordered for breast cancer screening.
Missed Incidental Finding on 2019 Breast MRI
Court proceedings focused on an April 2019 annual breast MRI performed at Legacy Good Samaritan for Wendi Lui, who underwent MRI screening in addition to mammography because she was considered at higher risk for cancer. Kari A. Thomas, MD, with Diagnostic Imaging NW, interpreted the study and reported no suspicious findings for breast cancer. The plaintiffs contended that the images also showed a lung cancer finding that should have been identified and reported, and that earlier recognition would have prompted additional workup while treatment options were more favorable.
The plaintiffs’ position emphasized that the alleged miss involved anatomy captured on the examination, not a separate diagnostic study. In advancing those claims at trial, the estate and Gene Lui were represented by Law Office of Rachel O’Neal. In public remarks after the verdict, attorney Rachel O’Neal described the case as implicating a structured approach to review of all visible anatomy on a breast MRI, including intrathoracic structures, and the need to report extra-mammary findings when present. The jury’s liability finding effectively credited that standard in the circumstances presented at trial.
Subsequent Imaging, Diagnosis, and Reported Disease Progression
The record described at trial included a later breast MRI in June 2020, more than a year after the 2019 screening examination. Sam Gruner, MD, also with Diagnostic Imaging NW, interpreted that study and identified a left lung mass described as suggestive of malignancy, recommending follow-up CT. A PET imaging exam in July 2020 ultimately confirmed non-small cell lung cancer. The report further noted that Wendi Lui had never smoked.
Wendi Lui died on Dec. 6, 2023, at age 51, from metastatic lung cancer. Additional details presented about timing and growth were used to contextualize the alleged harm: she underwent her first breast MRI in 2018 at age 46; a mass was described as approximately 1 centimeter at that time and as 2 centimeters by 2019. The finding was not identified until 2020, when its volume had reportedly tripled and it was described as comparable in size to a large grape. By the time of the 2020 identification, the disease had spread to lymph nodes, a fact the plaintiffs used to argue that the delay in recognition carried meaningful clinical consequences.
Trial Positions, Verdict, and Broader Significance
The dispute at trial was framed around what a careful radiologist should have done when interpreting the 2019 breast MRI without the benefit of hindsight. Defense counsel Mike Wiswall argued that the standard-of-care analysis must be limited to the information available at the time of the 2019 read, contending that Diagnostic Imaging NW should not be held liable based on later developments. Diagnostic Imaging NW also maintained publicly that its services met the applicable standard of care, while Legacy Health declined public comment on the verdict.
Gene Lui’s role also shaped the litigation’s trajectory. He pursued trial rather than resolution through pretrial offers, and the case was described as unusual in part because families often face practical constraints in challenging imaging interpretations. The lawsuit was filed in 2024, and timing issues were noted in connection with the 2018 scan, which was described as outside the statute of limitations. Legacy Health was named as a hospital partner in the case because the radiology practice provided care on its behalf, and the jury ultimately held both Diagnostic Imaging NW and Legacy Health liable in the nearly $8 million verdict.
Takeaways for Imaging Protocols and Risk Management
Although the trial was case-specific, the allegations and verdict underscore the importance of radiology workflows that account for incidental findings when non-target anatomy is captured on an exam. The plaintiffs’ theory rested on the premise that breast MRI interpretation may require assessment of intrathoracic structures visible in the field of view, with documentation and follow-up recommendations when abnormalities are identified. That framing, as applied by the jury, highlights how liability risk can extend beyond the organ system that prompted the study.
At trial, defense attorney Mike Wiswall argued that the 2019 interpretation should be assessed without knowledge of the later diagnosis. Diagnostic Imaging NW maintained that its services met the standard of care. On the defense side, representation included Forum Law Group, LLC, which advanced arguments challenging the asserted standard-of-care breach and causation narrative tied to timing. As similar cases arise, parties are likely to continue contesting how courts and juries should define the radiologist’s review obligations for incidental findings on screening studies and how those obligations interact with evolving imaging practices and documentation expectations.


